Specifically, CXCL14 activates the CCR7/JAK2/STAT3 axis, leading to the upregulation of ERCC4 transcription, which promotes DNA damage repair in bladder cancer cells, thereby facilitating the development of chemoresistance. The gene discussed is ERCC4; the disease is urinary bladder cancer.